All Stories

  1. Association between sociodemographic and clinical factors and utilization of hematopoietic cell transplant in acute myeloid leukemia from 2004 to 2020
  2. Academic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery
  3. Age and Sex-Based Differences in Therapy Preferences Among Patients with Cancer: Evidence from a Novel Therapy Preference Scale
  4. Effect of NPM1 mutation Subtype and Co-Mutation Patterns on the Outcomes of Patients with Acute Myeloid Leukemia; A Referral Center Experience
  5. Effect of Pre- and Peri-Transplant Measurable Residual Disease Clearance in Patients with Myelodysplastic Neoplasm; A Referral Center Experience
  6. Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020
  7. Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting
  8. Improved overall survival in acute myeloid leukemia over the last 15 years.
  9. Trends in hematopoietic cell transplantation (HCT) in acute myeloid leukemia (AML) from 2004-2019.
  10. Abstract 5852: Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia
  11. Abstract 6471: Trends in chemotherapy utilization in acute myeloid leukemia (AML) in last 15 years
  12. Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience
  13. Diet and Nutritional Supplementation in Patients With Cancer: Is More Necessarily Better?
  14. Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19
  15. Venetoclax-based therapy in treatment-naïve and relapsed/refractory acute myeloid leukemia
  16. Preferences of Patients with Acute Myeloid Leukemia and Other Myeloid Malignancies on Cancer Treatment: Effect of Patient- and Treatment-Characteristics?
  17. Therapy-related Acute Myeloid Leukemia in Non-Hodgkin Lymphoma Survivors: Risk, Survival Outcomes and Prognostic Factor Analysis
  18. Therapy preferences of patients with cancer.
  19. Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?
  20. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
  21. Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients
  22. Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders
  23. Venous Thromboembolism Risk Assessment in Hospitalized Cancer Patients: A Single Center Study
  24. Understanding the Treatment Preferences of Adults with Cancer
  25. Charlson comorbidity index predicts early mortality and overall survival in acute promyelocytic leukemia
  26. Effect of Age and Socioeconomic Factors in the Utilization of Chemotherapy in Acute Lymphoblastic Leukemia (ALL): A SEER Database Study of 16,196 Patients
  27. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study
  28. Precision Medicine in Myeloid Malignancies: Hype or Hope?
  29. Impact of Insurance on Overall Survival in Acute Lymphoblastic Leukemia: A SEER Database Study
  30. Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety
  31. Association of insurance types and outcomes in acute promyelocytic leukemia
  32. Predicting early mortality and overall survival (OS) in acute promyelocytic leukemia (APL) based on Charlson comorbidity index (CCI).
  33. Using Charlson comorbidity index (CCI) to predict outcomes of older patients with acute promyelocytic leukemia (APL).
  34. Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States
  35. Determinants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysis
  36. Preferences of Adults with Cancer for Systemic Cancer Treatment: Do Preferences Differ Based on Age?
  37. Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis
  38. Management of Cancer-Associated Thrombosis
  39. Overview of Cancer-Associated Thrombosis
  40. Pathophysiology and Risk Factors for CancerAssociated Thrombosis
  41. Catheter-Related Thrombosis in Cancer
  42. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?
  43. Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia
  44. Development and Validation of the Therapy Preference Scale to Understand Patients´ Systemic Cancer Treatmentpreferences
  45. Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia
  46. Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients
  47. Do USMLE steps, and ITE score predict the American Board of Internal Medicine Certifying Exam results?
  48. Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia
  49. Treatment Strategies for Therapy-related Acute Myeloid Leukemia
  50. Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia
  51. Do USMLE Steps, and ITE Score Predict the American Board of Internal Medicine Certifying Exam results?
  52. An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
  53. Pemetrexed Induced Life-threatening Anaphylaxis
  54. Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?
  55. Initial management of immune thrombocytopaenia in adults based on risk stratification
  56. Review for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"
  57. Effects Of Center Type and Socioeconomic Factors On Early Mortality And Overall Survival of Diffuse Large B-Cell Lymphoma
  58. Effectiveness of Sequential Compression Devices in Prevention of Venous Thromboembolism in Medically Ill Hospitalized Patients: A Retrospective Cohort Study
  59. Overutilisation of imaging studies for diagnosis of pulmonary embolism: are we following the guidelines?
  60. Spontaneous tumour lysis syndrome in small cell lung cancer: a rare phenomenon
  61. Serendipitous Discovery of Factor VII Deficiency and the Ensuing Dilemma
  62. Atypical Chronic Myeloid Leukemia: A Rare Entity with Management Challenges
  63. Central nervous system complications after allogeneic hematopoietic stem cell transplantation
  64. Penetrating aortic ulcer leading to aortic dissection
  65. Renal Cancer in Recipients of Kidney Transplant
  66. Chylothorax
  67. THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
  68. Use of Digital Technology to Optimize Functional Status in an Older Patient With Myelodysplastic Syndrome
  69. Clinical Features and Outcomes of Mycophenolate Mofetil-induced Diarrhea: A Systematic Review
  70. Mad Honey Poisoning: A Review
  71. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants
  72. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
  73. Cryptogenic Stroke
  74. Eculizumab in Transplant-Associated Thrombotic Microangiopathy
  75. An Algorithmic Approach to Management of Venous Thromboembolism
  76. New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review
  77. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
  78. Demographic and other characteristics of nodal non-Hodgkin’s lymphoma managed in academic versus non-academic centers
  79. Heparin Reexposure in Patients With a History of Heparin-Induced Thrombocytopenia
  80. Tuberous sclerosis complex with autosomal dominant polycystic kidney disease: a rare duo
  81. Aortic dissection as a rare complication of percutaneous coronary intervention
  82. Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma
  83. Polycystic kidney disease and chronic renal failure in tuberous sclerosis